Chemical and Biological Engineering/Molecular Biotechnology, Chalmers University of Technology, 412 96 Goteborg, Sweden.
Microb Cell Fact. 2010 Jun 17;9:47. doi: 10.1186/1475-2859-9-47.
Recombinant protein production is universally employed as a solution to obtain the milligram to gram quantities of a given protein required for applications as diverse as structural genomics and biopharmaceutical manufacture. Yeast is a well-established recombinant host cell for these purposes. In this study we wanted to investigate whether our respiratory Saccharomyces cerevisiae strain, TM6*, could be used to enhance the productivity of recombinant proteins over that obtained from corresponding wild type, respiro-fermentative strains when cultured under the same laboratory conditions.
Here we demonstrate at least a doubling in productivity over wild-type strains for three recombinant membrane proteins and one recombinant soluble protein produced in TM6* cells. In all cases, this was attributed to the improved biomass properties of the strain. The yield profile across the growth curve was also more stable than in a wild-type strain, and was not further improved by lowering culture temperatures. This has the added benefit that improved yields can be attained rapidly at the yeast's optimal growth conditions. Importantly, improved productivity could not be reproduced in wild-type strains by culturing them under glucose fed-batch conditions: despite having achieved very similar biomass yields to those achieved by TM6* cultures, the total volumetric yields were not concomitantly increased. Furthermore, the productivity of TM6* was unaffected by growing cultures in the presence of ethanol. These findings support the unique properties of TM6* as a microbial cell factory.
The accumulation of biomass in yeast cell factories is not necessarily correlated with a proportional increase in the functional yield of the recombinant protein being produced. The respiratory S. cerevisiae strain reported here is therefore a useful addition to the matrix of production hosts currently available as its improved biomass properties do lead to increased volumetric yields without the need to resort to complex control or cultivation schemes. This is anticipated to be of particular value in the production of challenging targets such as membrane proteins.
重组蛋白生产普遍被用作解决问题的方法,以获得所需的毫克到克数量的特定蛋白质,这些蛋白质的应用范围广泛,包括结构基因组学和生物制药制造。酵母是这些目的的一种成熟的重组宿主细胞。在这项研究中,我们想研究我们的呼吸酿酒酵母 TM6* 菌株是否可以用于提高重组蛋白的生产力,超过在相同实验室条件下培养的相应野生型、呼吸发酵型菌株所获得的生产力。
我们至少证明了在 TM6* 细胞中生产的三种重组膜蛋白和一种重组可溶性蛋白的生产力比野生型菌株提高了一倍。在所有情况下,这归因于该菌株更好的生物量特性。与野生型菌株相比,生长曲线的产率分布也更加稳定,并且通过降低培养温度不会进一步提高。这具有额外的好处,即在酵母的最佳生长条件下,可以快速获得提高的产量。重要的是,通过在野生型菌株中进行葡萄糖补料分批培养,无法重现提高的生产力:尽管已经达到了与 TM6* 培养物相似的生物量产量,但总比体积产率并没有相应增加。此外,在存在乙醇的情况下生长培养物对 TM6* 的生产力没有影响。这些发现支持了 TM6* 作为微生物细胞工厂的独特特性。
在酵母细胞工厂中生物量的积累不一定与正在生产的重组蛋白的功能产率成比例增加相关。这里报道的呼吸酿酒酵母菌株因此是生产宿主矩阵的有用补充,因为其改善的生物量特性确实导致了更高的比体积产率,而无需采用复杂的控制或培养方案。这预计在生产具有挑战性的靶标(如膜蛋白)方面特别有价值。